outcomes of sct in t-all and t-lbl
Published 6 months ago • 118 plays • Length 8:57Download video MP4
Download video MP3
Similar videos
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
4:45
safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
-
1:12
the safety and efficacy of mb-106 for the treatment of waldenström’s macroglobulinemia
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
1:22
safety and efficacy of ari0002h for r/r mm
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
22:26
what's your approach? treating myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
2:31
evaluating the safety of maintenance therapy cessation in mrd negative myeloma patients
-
4:19
commands study: efficacy & safety results and biomarker analysis
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
3:17
estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
2:19
insights into the phase iia mylox-1 trial: assessing efficacy of gb2064 in myelofibrosis
-
1:11
personalized risk assessment for transplantation in primary immunodeficiency disorders